Morphic Therapeutic
Show contact
Gustav Christensen was President and CEO of Dyax Corp (NASDAQ: DYAX) from January 1, 2009 till it was acquired by Shire for $6.5 billion in January 2016. He joined Dyax early 2007 as EVP and Chief Business Officer.
Scott L. Friedman
Advisor
Otello Stampacchia
Director
Joseph P. Slattery
Martin Edwards
Timothy Springer
Amir Nashat
Yury V. Popov
Scientific Advisor
Shelia Violette
+ 10 more
14 members
Current role
Gustav Christensen